Getinge limits sale of heart devices in the US after FDA warning
(Reuters) - Sweden's Getinge will limit sales of some of its heart products in the U.S., the medical equipment maker said late on Tuesday, after recent advice from the U.S. Food and Drug Administration (FDA) to move away from its devices. "We have ...
May 15, 2024
No shortage of Wegovy weight-loss drug in Denmark, Novo Nordisk says
COPENHAGEN (Reuters) - Novo Nordisk does not expect a shortage of its Wegovy weight-loss drug in Denmark despite an earlier warning by the Danish Medicines Agency of strained supply of two separate doses in the coming weeks, the company said. The D...
May 15, 2024
Novo Nordisk owner buys majority stake in Austrian life science tools company
By Maggie Fick LONDON (Reuters) - Novo Holdings, the controlling shareholder of Danish obesity drugmaker Novo Nordisk, said on Wednesday it would buy a controlling stake of about 60% in Single Use Support, an Austria-based life science tools compan...
May 15, 2024
Roche says FDA approves HPV self-test in US
BERLIN (Reuters) - Swiss drugmaker Roche on Wednesday said the US Food and Drug Administration (FDA) has approved its human papillomavirus (HPV) self-testing kit. Screening for HPV can help identify women who are at risk of developing cervical canc...
May 15, 2024
Merck KGaA's Q1 adjusted profit declines less than feared
By Ludwig Burger FRANKFURT (Reuters) - Merck KGaA on Wednesday reported better-than-expected adjusted earnings, helped by strong demand for its pharmaceuticals and amid currency-adjusted sales growth in semiconductor materials. The German diversifi...
May 15, 2024
Taiwan says WHO should let it attend all its meetings
TAIPEI (Reuters) - Taiwan Foreign Minister Joseph Wu called on the World Health Organization on Wednesday to allow the island to attend all its meetings if it is serious about its goal of "Health for All", ahead of a key summit Taipei wants to take...
May 15, 2024
Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
(Reuters) - Eisai and partner Biogen said on Tuesday that the Japanese drugmaker has begun submitting data on a rolling basis to the US health regulator for a marketing application of a subcutaneous form of their Alzheimer's disease drug Leqembi. T...
May 14, 2024
Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs
(Reuters) - Eli Lilly has entered into a settlement deal with a medi spa that had sold counterfeit versions of its popular diabetes drug Mounjaro and weight loss treatment Zepbound, the drugmaker said on Tuesday. As part of the deal, Totality Medis...
May 14, 2024
Activist Jana Partners built position in QuidelOrtho in first quarter, sources say
By Svea Herbst-Bayliss (Reuters) - Activist investor Jana Partners built a new stake in U.S. diagnostics company QuidelOrtho during the first quarter, sources familiar with the hedge fund's position told Reuters. It is unclear whether the hedge fun...
May 14, 2024
Grifols swings to profit, says debt reduction on track
By Joan Faus BARCELONA (Reuters) - Spanish drugmaker Grifols swung to a first-quarter net profit of 21 million euros ($23 million) from a year-ago loss, and said on Tuesday it was on track to meet its 2024 outlook, including cutting debt. Grifols, ...
May 14, 2024
CDC makes public influenza A wastewater data to assist bird flu probe
(Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday released data on influenza A found in wastewater in a public dashboard that could assist in tracking the outbreak of H5N1 bird flu that has infected cattle herds. Las...
May 14, 2024
US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine
(Reuters) - The U.S. Food and Drug Administration has declined to approve the expanded use of Dynavax Technologies' hepatitis B vaccine in patients undergoing hemodialysis, the company said on Tuesday. (Reporting by Christy Santhosh and Pratik Jai...
May 14, 2024
Bayer's Q1 adjusted profit beats analyst consensus
FRANKFURT (Reuters) - Bayer on Tuesday reported a 1.3% decline in adjusted earnings in the first quarter, beating analysts' forecasts on better-than-expected performance at its prescription drugs and agriculture divisions. Quarterly earnings before...
May 14, 2024
Wegovy weight loss sustained for four years in trial, Novo Nordisk says
By Maggie Fick LONDON (Reuters) - Patients taking Novo Nordisk's popular Wegovy obesity treatment maintained an average of 10% weight loss after four years on the treatment, the company said on Tuesday. Novo presented the new long-term data at the ...
May 14, 2024
US reclassification could drive fresh research funding into pot sector
By Mrinalika Roy (Reuters) - The U.S. pot sector could see an influx of medical research funding from healthcare investors amid renewed interest from pharmaceutical firms, should a proposal to reclassify cannabis as a lower-risk substance be approv...
May 13, 2024
Denmark faces Wegovy shortage due to rising demand, medicines agency says
COPENHAGEN (Reuters) -The Danish medicines agency on Monday warned of a supply shortage for two separate doses of Novo Nordisk's hugely popular weight loss drug Wegovy due to increasing demand. Wegovy is given by weekly injection and belong to a class ...
May 13, 2024
Edwards Lifesciences hit with Meril's EU antitrust complaint
By Foo Yun Chee BRUSSELS (Reuters) - U.S. heart valve maker Edwards Lifesciences has been hit with an EU antitrust complaint by Indian rival Meril including for allegedly anti-competitive practices related to patents, a move that could bolster EU r...
May 13, 2024
Turkey arrests spider smuggler said to be American Museum of Natural History curator
ISTANBUL (Reuters) - Turkish police arrested a man suspected of trying to smuggle valuable poisonous spiders and scorpions out of the country, with state media identifying the suspect on Monday as a curator at New York's American Museum of Natural...
May 13, 2024
Merck stops skin cancer combination therapy testing in late-stage study
(Reuters) -Merck has discontinued testing a combination of an experimental antibody-based drug and its blockbuster immunotherapy, Keytruda, for some patients with the most severe form of skin cancer in a late-stage study, it said on Monday. The decisio...
May 13, 2024
Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial
TOKYO (Reuters) - Japan's Shionogi & Co said on Monday its pill-based treatment for COVID-19 did not meet the primary endpoint of showing a statistically significant reduction of 15 common symptoms of the illness in a global, late-stage trial. The ...
May 13, 2024
Sanofi pledges new 1 billion euros worth of investments in French production sites
PARIS (Reuters) - Sanofi on Monday announced it would invest over 1 billion euros ($1.1 billion) to create new medicines and vaccine production capacities at three of its French sites. The announcement came ahead of this year's "Choose France" even...
May 13, 2024
Analysis-Before global scrutiny, Indian spice maker MDH faced many US rejections
By Rishika Sadam HYDERABAD, India (Reuters) - Popular Indian spice brand MDH, under scrutiny for alleged contamination in some products, has since 2021 seen an average 14.5% of its U.S. shipments rejected due to the presence of bacteria, a Reuters...
May 12, 2024
Fresenius Medical sees up to 2% US dialysis growth by year-end
FRANKFURT (Reuters) - The number of kidney dialysis sessions provided by Fresenius Medical Care in its top market, the United States, could rise by as much as 2% by the end of the year, its CEO said, as the impact of the pandemic on patients fades....
May 11, 2024
Final tests of US dairy samples are negative for bird flu virus, US FDA says
CHICAGO (Reuters) - Final testing of U.S. retail dairy samples came back negative for viable H5N1 bird flu virus, the Food and Drug Administration said on Friday. The FDA said it finished its laboratory research into 297 retail dairy samples tested...
May 10, 2024
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows
(Reuters) - About one in eight adults have taken a drug belonging to the GLP-1 class of medications for weight loss and related conditions, a poll by Kaiser Family Foundation (KFF) showed on Friday. The data also showed that 6% of those polled said...
May 10, 2024